in pharmacology, it's important to not disobey existing protocols for drug development despite the pressure to re-establish ourselves in the market quickly; however, during preconsultative phases, often there's a disclosure of information that ensures all data regarding side effects becomes unrecognizable, ultimately putting patient health at risk by withholding crucial safety information.